Table 6. Sensitivity analysis of the included studies to estimate the prevalence of MDR bacteria among HIV-positive individuals in Ethiopia.
Study omitted | Estimate (95% confidence interval) | Heterogeneity | |
---|---|---|---|
I2 (%) | p-value | ||
Tilahun et al, 2023 | 56.71 (44.74–68.68) | 96.8 | < 0.001 |
Adhanom et al, 2019 | 59.98 (48.54–71.43) | 96.8 | < 0.001 |
Genetu & Zenebe, 2020 | 57.06 (44.93–9.20) | 97.2 | < 0.001 |
Ayele et al, 2020 | 57.34 (45.38–69.38) | 97.2 | < 0.001 |
Alebachew et al, 2016 | 58.17 (46.11–70.23) | 97.2 | < 0.001 |
Tilahun et al, 2023 | 56.88 (44.84–68.92) | 97.2 | < 0.001 |
Tessema et al, 2020 | 57.12 (45.08–69.14) | 97.2 | < 0.001 |
Abebe et al, 2014 | 56.52 (44.69–68.34) | 96.8 | < 0.001 |
Gebre et al, 2022 | 60.25 (48.93–71.58) | 96.7 | < 0.001 |
Bayleyegn et al, 2021 | 59.01 (46.84–71.18) | 97.1 | < 0.001 |
Jemal et al, 2020 | 57.05 (44.81–69.23) | 97.1 | < 0.001 |
Manilal et al, 2019 | 59.92 (48.28–71.57) | 96.9 | < 0.001 |
Dadi et al, 2021 | 58.44 (46.17–70.72) | 97.2 | < 0.001 |
Fenta et al, 2016 | 57.81 (45.68–69.94) | 97.2 | < 0.001 |
Simeneh et al, 2022 | 58.22 (46.14–70.30) | 97.2 | < 0.001 |
Hantalo et al, 2020 | 57.04 (44.99–69.08) | 97.2 | < 0.001 |
Muhaba et al, 2022 | 58.18 (45.85–70.50) | 97.2 | < 0.001 |
Seid et al, 2020 | 59.35 (47.38–71.31) | 97.2 | < 0.001 |
Mulu et al, 2018 | 59.50 (47.74–71.24) | 96.8 | < 0.001 |
Adisu et al, 2023 | 56.98 (44.97–69.00) | 97.2 | < 0.001 |
Zike et al, 2024 | 56.57 (44.66–68.50) | 96.9 | < 0.001 |
Mitiku et al, 2023 | 58.45 (46.32–70.58) | 97.2 | < 0.001 |